GENEREX BIOTECHNOLOGY Trademark

Trademark Overview

On Tuesday, December 5, 2000, a trademark application was filed for GENEREX BIOTECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the GENEREX BIOTECHNOLOGY trademark a serial number of 76176126. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 15, 2007. This trademark is owned by Generex Biotechnology Corporation. The GENEREX BIOTECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations administerable through mucous membranes for the treatment of diabetes, prostate cancer, endometriosis, breakthrough cancer pain, and for use in providing anticoagulant therapy in the treatment of heart disease
generex biotechnology

General Information

Serial Number76176126
Word MarkGENEREX BIOTECHNOLOGY
Filing DateTuesday, December 5, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 15, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 6, 2004

Trademark Statements

Disclaimer with Predetermined Text"BIOTECHNOLOGY"
Goods and ServicesPharmaceutical preparations administerable through mucous membranes for the treatment of diabetes, prostate cancer, endometriosis, breakthrough cancer pain, and for use in providing anticoagulant therapy in the treatment of heart disease

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 15, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENEREX PHARMACEUTICALS INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressTORONTO, ONTARIO M5J 2G2
CA
Party NameGenerex Biotechnology Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto Ontario M5G 2G2
CA
Party NameGenerex Biotechnology Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto Ontario M5G 2G2
CA

Trademark Events

Event DateEvent Description
Tuesday, January 22, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Tuesday, January 22, 2008ABANDONMENT - NO USE STATEMENT FILED
Saturday, July 28, 2007EXTENSION 5 GRANTED
Thursday, April 12, 2007EXTENSION 5 FILED
Wednesday, June 6, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 13, 2007PAPER RECEIVED
Thursday, February 15, 2007EXTENSION 4 GRANTED
Monday, October 2, 2006EXTENSION 4 FILED
Monday, October 2, 2006PAPER RECEIVED
Thursday, May 4, 2006EXTENSION 3 GRANTED
Wednesday, April 12, 2006EXTENSION 3 FILED
Tuesday, April 18, 2006PAPER RECEIVED
Saturday, October 15, 2005EXTENSION 2 GRANTED
Friday, September 30, 2005EXTENSION 2 FILED
Friday, September 30, 2005PAPER RECEIVED
Tuesday, May 3, 2005EXTENSION 1 GRANTED
Thursday, April 7, 2005EXTENSION 1 FILED
Thursday, April 7, 2005PAPER RECEIVED
Thursday, December 23, 2004PAPER RECEIVED
Tuesday, October 12, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 18, 2004EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, February 4, 2004EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 6, 2004PUBLISHED FOR OPPOSITION
Wednesday, December 17, 2003NOTICE OF PUBLICATION
Friday, November 14, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 10, 2003REINSTATED
Wednesday, June 25, 2003PAPER RECEIVED
Friday, June 13, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, October 10, 2002NON-FINAL ACTION MAILED
Tuesday, October 8, 2002ASSIGNED TO EXAMINER
Thursday, June 13, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 17, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 13, 2001NON-FINAL ACTION MAILED
Thursday, November 1, 2001EXAMINERS AMENDMENT MAILED
Thursday, May 17, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 5, 2001NON-FINAL ACTION MAILED
Friday, March 30, 2001ASSIGNED TO EXAMINER

Related Keywords

biotechnology generex treatment cancer pain breakthrough providing anticoagulant disease heart therapy endometriosis